Girard Partners’s VivoSim Labs VIVS Stock Holding History

Girard Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4	Closed	-$1K	–	852
2018 Q3	$1K	Buy	+4	New	+$1.2K	﹤0.01%	931

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Girard Partners's VIVS Position: Q4 2018 in Review

Girard Partners sold out of VivoSim Labs (VIVS) in Q4 2018, closing a stake of 4 shares — an estimated $1K sold.

Girard Partners first reported a position in VIVS in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 114 funds tracked by Wall St. Rank hold VIVS as of Q4 2018.

Girard Partners reported no remaining VivoSim Labs position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 4 VivoSim Labs shares in Q4 2018, an estimated $1K.
Girard Partners first reported a position in VivoSim Labs in Q3 2018 and held it in 1 quarter.
Girard Partners's VivoSim Labs position peaked at $1K in Q3 2018.
114 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.